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Abstract
Objectives: Pulmonary Tuberculosis (TB) is a disease that is often treated medically. However, medical treatment usually fails in
the management of tuberculosis e related hemoptysis. In this study, we aimed to assess the role of surgery in the treatment of
hemoptysis due to pulmonary TB.
Methods: Fifty two patients presented by hemoptysis and underwent pulmonary resection were enrolled in this study. Patients were
divided into two groups according to the timing of surgical procedures:GroupA (n¼ 22) included patients who underwent surgery
within two days of presentation which was major to massive hemoptysis causing hemodynamic instability. Group B (n ¼ 30)
included patients who underwent surgery within 4 days after presentation with hemoptysis which was persistent and minor.
Results: There was no significant difference in the demographic data between both groups. Major and massive hemoptysis were the
common presentation of group A, whereas minor hemoptysis was the main presentation in group B. Tuberculous cavities were the
most common lung lesions in both groups (40.9% in group A, versus 40% in group B). Lobectomy was the main surgical procedure
performed in both groups (50% in group A, versus 56.7% in group B). Regarding the complications, Bronchopleural fistula
occurred in one case in each group after pneumonectomy. Recurrent hemoptysis occurred in only one case in group A. There was
one case (4.5%) of mortality in group A.
Conclusion: Early pulmonary resection in patients with hemoptysis is an effective and safe method to insure good outcome.
Limited resections are associated with higher incidence of recurrence.
Copyright © 2016, Publishing services by Elsevier B.V. on behalf of The Egyptian Society of Cardio-thoracic Surgery. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Hemoptysis is one of the commonest and challenging clinical symptoms encountered in the practice of routine and
emergency respiratory medicine. Massive hemoptysis is a significant event that frightens the patients and often* Corresponding author. Tel.: þ20 01277280480.
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massive hemoptysis. This may partly be due to the wide variety of causes that lead to this event [1].
In the era of modern thoracic surgery, An interdisciplinary team work is mandatory to identify TB patients who can
benefit from surgery [2].
Hemoptysis is not an unusual finding in patients with old or active pulmonary tuberculosis. Because of bronchial
artery or a branch of pulmonary artery erosion due to cavitary infiltration, bronchiectasis, fungus ball, broncholithiasis
or destroyed lung, the bleeding can sometimes be a life-threatening situation. Assessment of the patient and finding the
exact site of bleeding can be difficult especially in a patient with disseminated lung disease [3].
The aim of this study was to evaluate the outcome of surgery in patients with hemoptysis due to pulmonary
tuberculous lesions.2. Patients and methods
2.1. Study design
After approval for the study protocol by the Menoufia Ethics Committee and an informed signed consent from all patients
included in the study, we conducted a prospective observational study in the Cardiothoracic Surgery Department, and Chest
Diseases Department in Menoufia University Hospitals from October 2010 to December 2015.
All the patients (n¼ 52) were previously diagnosed as having pulmonary tuberculosis and under antituberculous chemotherapy at the
time of presentationwith hemoptysis or had previously received a full course of antituberculous drug therapy and admittedwith hemoptysis.
Based on the quantity of blood expectorated per day, hemoptysis was classified into three groups: persistent minor (less 200 ml
daily, lasting at least 4 days), major (200e600 ml daily), and massive (more than 600 ml daily) [4,5].
Patients were divided into two groups according to the timing of surgical procedures: Group A (n ¼ 22) included patients who
underwent surgery within two days of presentation with hemoptysis due to hemodynamic instability. Hemoptysis was major to
massive in patients of this group. Group B (n ¼ 30) included patients who underwent surgery within 4 days after presentation with
hemoptysis which was minor.
2.2. Preoperative preparation
All patients underwent the following: medical history and clinical examination, Routine laboratory tests were done at admission
and preoperatively: complete blood count (CBC); liver and kidney function tests; fasting and two hours post-prandial blood sugar and
coagulation profile. Patients with hemoglobin <9 gm/dl received packed red blood cells (RBCs) before surgery. chest X-ray, PA and
lateral views, computed tomography (CT)-chest scan with contrast, sputum analysis for acid fast bacilli for at least three successive
days, and fiberoptic or rigid bronchoscopy as a preoperative procedure to localize the bleeding area and bronchoalveolar lavage (BAL)
for acid fast bacilli and cytological analyses. Triple anti-tuberculous chemotherapy (Anti-TB chemotherapy) with isoniazid (5 mg/kg
daily), rifampin (10 mg/kg daily), and ethambutol (25 mg/kg daily) was maintained in all patients currently taking medication.
Preoperative echocardiography and electrocardiography (ECG) were performed in all cases. Preoperative pulmonary function
tests were performed in 15 cases, from group B after stabilization of the condition. Pulmonary resection was done via posterolateral
thoracotomy and endotracheal intubation by a double-lumen endotracheal tube in all patients. Pneumonectomy was made in the
case of a destroyed lung, lobectomy or bilobectomy in the case of a cavitary lesion occupying one or two lobes, and segmentectomy
or wedge resection in the case of a cavitary lesion occupying one or more segments.
2.3. Postoperative Anti-TB chemotherapy
Patients were recommenced for their preoperative anti-TB chemotherapy regimen as soon as they resumed oral intake after
surgery with the possible adjustment of chemotherapy after analysis of the bacteriological results of the surgical material (resected
lung tissue). Postoperative chemotherapy is as indispensable as preoperative chemotherapy because after resection of the main lung
lesion, scattered nodular lesions and tiny cavities may be left behind. It is, therefore, vital to ensure that all patients [ in particular
those with Multi-drug/Extensive drug resistance (M/XDR-TB) ] remain on multidrug anti-TB regimens for a sufficiently long
period to kill the bacilli present at the remaining lesions. The following durations of anti-TB chemotherapy were followed,
depending on whether patients are culture-positive or culture-negative at the time of surgery:
(I) For culture-positive patients at the time of surgery: a-With susceptible TB, four to six months after culture conversion. b-With
MDR-TB (resistance to both Isoniazid and the Rifampicin), at least 18 months after culture conversion, and, c-with XDR-TB
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Amikacin), at least 24 months after culture conversion.
(II) For culture-negative patients at the time of surgery: a-With susceptible TB, at least four months after surgery. b-With M/
XDR-TB, six to eight months after surgery (depending on postoperative recovery) [6e8].
2.4. Statistical analysis
Results were analyzed using SPSS version 19 (SPSS IBM., Chicago, IL, USA). Continuous variables, such as age were
expressed as the mean± S.D. and compared by unpaired t-test. Categorical variables were expressed by number (n) and frequencies
(%). The c2-test and fischer exact test were used to compare the proportions. A P-value of <0.05 was considered statistically
significant.
3. Results
Table 1 showed baseline demographic and clinical characteristics of the studied groups. Patients of both group A
and B did not differ significantly as regards age, sex, smoking habits, and prevalence of diabetes mellitus, hypertension
and antituberculous drug resistance.
Table 2 showed that minor hemoptysis was considered the main symptom of group B, while major and massive
hemoptysis were the common presentation of group A. Tuberculous cavities were the common lung lesions in bothTable 1
Baseline Characteristics of the studied patients.
Group A (n ¼ 22) Group B (n ¼ 30) P-value
Age (mean ± SD)a 50 ± 14.7 47.5 ± 12 0.4
Sex n (%)b
Male 17 (77.3) 22 (73.3) 0.74
Female 5 (22.7) 8 (26.7)
BMI (mean ± SD)a 17.07 ± 1.58 16.87 ± 1.64 0.73
Multi-drug Resistance n (%)b 5 (22.7) 5 (16.6) 0.58
Bronchial asthma n (%)b 3 (13.6) 4 (13.3) 0.92
Smoking n (%)b 7 (31.8) 9 (30) 0.88





Etiological types and operative data.
Group A n ¼ 22 Group B n ¼ 30 P-value
Aetiology n (%)a
T.B cavity 9 (40.9) 12 (40) 0.94
Bronchiectasis 7 (31) 8 (26.7) 0.68
Destroyed Lung 4 (18.2) 8 (26.7) 0.47
Aspergilloma 2 (9.09) 2 (6.7) 0.74
Classification of Hemoptysis n(%)b
Minor 2 (9.09) 25 (83.3) <0.0001
Major 11 (50) 3 (10) 0.003
Massive 9 (40.9) 2 (6.7) 0.005
Types of Resection n(%)a
Lobectomy 11 (50) 17 (56.7) 0.63
Bilobectomy 2 (9.09) 4 (13.3) 0.67
Pneumonectomy 7 (31.8) 8 (26.7) 0.68
Wedge resection 1 (4.5) 1 (3.3) 0.79
Segmental resection 1 (4.5) 0 (0) 0.23
a Chi-square test.
b Fischer exact test.
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study, where it was 31% (7/22), 26.7% (8/30) in group A and B respectively, (Fig. 1). Destroyed lung was represented
in 18.2% (4/22) of patients in group A, while it was 26.7% (8/30) of patients in group B, (Fig. 2). Aspergilloma was
represented as 9.09% (2/22) of patients in group A, versus 6.7% (2/30) of patients in group B, (Fig. 4).
Lobectomy was the main surgical procedure performed in both groups (50% in group A, and 56.7% in group B),
however, other surgical procedures were performed, such as pneumonectomy, segmental resection, bilobectomy, But
wedge resection was done only in one case in each group B.Fig. 1. C.T chest-pulmonary window shows left lower lobe bronchiectasis.
Fig. 2. C.T chest pulmonary window shows destroyed left lung.
Fig. 3. C.T chest-pulmonary window shows right upper lobe cavitary lesion.
Fig. 4. C.T chest-pulmonary window shows left upper lobe cavitary lesion; aspergilloma.
Table 3
Complications.
Group A n ¼ 22 Group B n ¼ 30 P-value
Recurrent Hemoptysis 1 (4.5) 0 (0) 0.23
Bronchopleural fistula 1 (4.5) 1 (3.3) 0.79
Empyema 1 (4.5) 1 (3.3) 0.79
Bleeding 1 (4.5) 0 (0) 0.23
Pneumonia 1 (4.5) 1 (3.3) 0.79
Wound Infection 1 (4.5) 1 (3.3) 0.79
Prolonged air leak >7 days 2 (9) 1 (3.3) 0.37
Prolonged mechanical ventilation 2 (9) 1 (3.3) 0.37
Completion pneumonectomy 1 (4.5) 0 (0) 0.23
Mortality 1 (4.5) 0 (0) 0.23
Test of significance is chi-square.
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occurred in one case in group A after a segmental resection but there was no recurrence in group B. There was one case
of mortality in group A due to massive hemoptysis and aspiration to the other side but no mortality in group B.
Prevalence of other complications like hemorrhage, empyema, prolonged air leaks, prolonged mechanical ventilation,
and completion pneumonectomy showed no statistically significant difference in both groups.4. Discussion
Although most surgery for TB is elective, directly life-threatening conditions that may require emergency surgery
are at times found with all forms of TB. Based on the review of studies, Currently the surgical indications in pul-
monary TB are: TB complications (e.g., hemoptysis, empyema, cavity formation associated with aspergilloma,
adenopathy with fistula); cases displaying an inappropriate healing response to medication, in which clinical and
radiological pictures remain unchanged or indicate progression (e.g., cavity, tuberculoma); acid-fast bacilli sputum
smears positivity after 3-month treatment period, with a circumscribed radiological lesion or a destroyed lung; and
previous relapse(s) in patients with histories of TB and proper drug regimen. The management of post-resection
complications is still debated, featuring a wide range of procedures in order to reinforce the bronchial stump, to
sterilize the residual cavity, and to obliterate it. The harvested pedicled latissimus dorsi and serratus anterior muscle
graft transferred to affected side can fill out the residual post-resection space [7,9].
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causes from bronchitis to malignancy can lead to hemoptysis. Massive or recurrent hemoptysis may be life-
threatening. Pulmonary TB is one of the most well known etiologies for hemoptysis; however, there are many
types of tuberculous lesions which lead to hemoptysis [10].
Among various treatment options used for hemoptysis apart from surgical therapy are cold saline solution lavage
by bronchoscopy, endobronchial balloon tamponade with or without endobronchial instillation of epinephrine,
instillation of thrombin or fibrinogen-thrombin infusion endobronchially through fiberoptic bronchoscopy, laser
photocoagulation, radiotherapy, and bronchial artery embolization [2,11,12].
The individual preoperative assessment of each patient is crucial and consists of the following criteria: which anti-
TB chemotherapy regimen(s) a patient has previously received; and for how long; measurement of the bacteriological,
clinical and radiological progress or deterioration during and since the administration of each regimen; evaluation of
the current treatment strategy, including the indications for surgery. Anti-TB chemotherapy before surgery should be
at least three months in duration, in order to avoid serious and potentially fatal complications of TB surgery [11].
Pulmonary resection combined with anti-TB chemotherapy for MDR-TB achieves high treatment success rates (up to
88e92% of the cases) [13].
The time of surgery remains a matter of debate, early interference in massive or major hemoptysis was life-saving
in our series because the majority of our patients in group A had massive or major hemoptysis. Tuberculous cavities
represent 40.9% in group A, and 40% in group B, and are the most common lesions in our study. Major and massive
hemoptysis represented mainly in group A in accompany with cavitary lesions therefore, they are considered one of
the dangerous lesions that need rapid surgical interference. Other lesions like post tuberculous bronchiectasis 28.8%
(15/52) are considered the second most common cause after cavitary lesions in our study, while destroyed lung was
23% (12/52), and aspergilloma was 7.7% (4/52).
Neptune et al. reported that the lobectomy rate was 41.6% and the pneumonectomy rate was 5.4% [14]. In our
study, Lobectomy was the most common surgical interference in both groups A and B (50% and 56.7%, respectively),
but pneumonectomy was the second most common surgical interference in group A, 31.8% (7/22) as in group A the
majority of cases were treated under emergency conditions, the hemoptysis was severe to massive and radical
resection was mandatory and curative. Wedge and segmental resections were limited to a small percentage of our
cases; Furak et al. nevertheless recommend parenchyma-sparing resections in TB cases, with regards to the possibility
of carrying out further resections which may become necessary at a later date [15].
Erdogan and colleagues reported a series of 59 tuberculosis patients with hemoptysis who underwent surgical
resection. The pneumonectomy rate was 7% while lobectomy was performed in 65% and the lesser resections in 28%
with overall perioperative mortality about 7% [16]].
Management of massive hemoptysis and timing of surgical intervention pose difficult problems. Emergency
surgery should be reserved only for those patients: (I) continuing hemoptysis despite the adequate measures taken. (II)
exact site of bleeding definitely defined; (III) having adequate lung function [16].
Emergency surgery performed for massive hemoptysis has always-higher risk than a planned surgery as reported
by Jougon and colleagues [17].
Most important reasons for increased mortality in emergency situation are the continuing bleeding during the
operation and proceeding aspiration to uninvolved lung and hypovolemia. So, deciding to perform an emergency
surgical resection in a patient with massive hemoptysis remains a real challenge [3].
In most emergency cases, the patient had already aspirated some blood to the other lobe(s) and lung functions were
already disturbed. Resection of the lung parenchyma may lead respiratory insufficiency. For this reason, some authors
prefer that the amount of lung resection should be as small as possible while resecting the main source of bleeding. In
most cases, a lobectomy is the standard operation. Because in most cases it is not possible to define the bleeding
segment, a segmental resection is rare. In some cases, pneumonectomy is inevitable due to whole lung involvement
(destroyed lung) or when the bleeding site is lateralized but not localized. The complication rate is reported to increase
by emergency pneumonectomy compared to emergency lobectomy (72% vs. 52%) [4].
Another factor that increases the operative risk is the condition of the lung. Generally accompanying dense pleural
adhesions, presence of enlarged sticky lymph nodes, bronchiectasis make the surgery very complex and difficult one.
Some authors described a method called ‘lung exclusion’ in patients having dense adhesions making the hilar
dissection impossible. In that method, only the bronchus and the artery of affected lobe or lung are obliterated without
resection [18].
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comes of anatomic lung resection for hemoptysis in the USA covering a 10-year period, Over 457,000 admissions for
the diagnosis of hemoptysis were identified. The rate of tuberculosis patients was 0.8% [4322/457,000]. Of all patients
with hemoptysis, 2671 patients (0.58%) underwent surgical resection, 47 (1.8%) for tuberculosis and 157 (5.9%) for
fungal infection. This study showed that the increased age and pneumonectomy were the most important risk factors
for operative mortality while tuberculosis was not [19].
Rizzi et al., [20] reported in their study that, the average morbidity was 29.1%. In our study, Postoperative
complications, such as hemorrhage, empyema, prolonged air-leak, and prolonged mechanical ventilation were minor.
The major complications were BPF and recurrent hemoptysis. Overall morbidities were 34.6% (18/52). This was
similar to that in the study done by Mohsen TA, and Abou Zeid A, when they reported that overall complications
percentage was 34.7% after pulmonary resection for T.B patients [21].
Bronchopleural fistula (BPF) occurred in 3.84% (2/52) in our study, Both of them were drug resistant. Erdogan
et al. reported that BPF was 5.1% in their study [16]. While Rizzi et al. reported that the frequency of BPF after
pneumonectomy in TB was 1.9% [20].
Erdogan and colleagues reported three cases of empyema and BPF in their series containing 59 patients who were
operated for T.B related hemoptysis. Two of the BPF were reported to develop after pneumonectomy (50%) showing
the increased risk after pneumonectomy [16].
In our study the mortality rate was reported in one case in group A, and no mortalities in group B, whereas the
overall mortality rate was 1.9% (1/52) despite the severity of hemoptysis and compared quite favorably with the other
published series where the mortality rate after lobectomy was about 2e3% and after pneumonectomy about 7e8%
[22]. Other published studies have demonstrated mortality ranging from 0% to 3.1% [23]. Whereas, El Sadeck N, and
Ezzat N, reported mortality rate of 38.1% in their study on 84 patients with massive hemoptysis when they underwent
pneumonectomy or lobectomy [24].
While nonsurgical approaches and medications are considered as first-line treatment to manage minor hemoptysis,
Massive, major and persistent minor hemoptysis should be treated early by pulmonary resection to prevent possible
further recurrences.5. Conclusion
Major and massive hemoptysis are usually accompanied by cavitary lesions which are the most common type of
tuberculous pulmonary lesions. So we recommend early surgical resection of T.B cavities to avoid fatal hemoptysis
with limited use of wedge and segmental resections to avoid the recurrence of hemoptysis.Conflict of interest
No conflicts of interest.
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